McNeil Michael D.

SEC source: 0001641172-25-024864 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Ch. Acct. & Ch. Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,587

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the accelerated vesting of 9,543 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the accelerated vesting of 9,543 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001641172-25-003840 · ownership.xml · nonDerivative · entry 4

McNeil Michael D. · CIK 0001737969 · Ch. Acct. & Ch. Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,911

F4 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,486 shares of restricted stock granted to the reporting person on March 19, 2025. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F4 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,486 shares of restricted stock granted to the reporting person on March 19, 2025. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001641172-25-003840 · ownership.xml · nonDerivative · entry 3

McNeil Michael D. · CIK 0001737969 · Ch. Acct. & Ch. Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,273

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,550 shares of restricted stock granted to the reporting person on March 7, 2024. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,550 shares of restricted stock granted to the reporting person on March 7, 2024. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001641172-25-003840 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Ch. Acct. & Ch. Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,651

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,406 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,406 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001641172-25-003840 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Ch. Acct. & Ch. Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,994

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,183 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,183 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-25-011142 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Ch. Acct. & Ch. Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,521

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock vested in full on the date of grant.

SEC source: 0001493152-25-008521 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Ch. Acct. & Ch. Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,035

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on February 25, 2026, 2027 and 2028, respectively.

SEC source: 0001493152-24-009563 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,998

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 7, 2025, 2026 and 2027, respectively.

SEC source: 0001493152-24-008907 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,348

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,405 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,405 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-008907 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,947

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-004970 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,634

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,036 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,036 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-012318 · ownership.xml · derivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2023-04-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the terms of the option award agreement, the option vested in full on March 15, 2019 in connection with the closing of the Share Exchange Agreement between the issuer and CGI Cellerate RX, LLC, which was deemed to be a change of control of the issuer.

SEC source: 0001493152-23-012318 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-23-008367 · ownership.xml · nonDerivative · entry 3

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,025

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,182 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008367 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,557

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008367 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,810

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,699 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,699 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-006857 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,468

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2024, 2025 and 2026, respectively.

SEC source: 0001493152-22-034630 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,251

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,035 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034630 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,504

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,546 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,546 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-006538 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,369

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively.

SEC source: 0001493152-21-032527 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,822

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three installments, with one-third of the shares vesting on February 1, 2022, and the remainder vesting in two equal installments on February 1, 2023 and 2024, respectively.

SEC source: 0001493152-21-032041 · ownership.xml · nonDerivative · entry 3

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,716

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 623 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 623 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032041 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,868

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 624 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 624 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032041 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,020

F1 · shares: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,546 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,546 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0000897423-20-000095 · edgar.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,884

SEC source: 0000897423-20-000057 · edgar.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,637

SEC source: 0000897423-20-000057 · edgar.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,540

SEC source: 0000897423-20-000028 · edgar.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 8,097 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

F2 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 8,097 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

SEC source: 0000897423-20-000028 · edgar.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,097

F1 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 2,540 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

F1 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 2,540 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

SEC source: 0000897423-20-000019 · edgar.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,637

SEC source: 0000897423-20-000019 · edgar.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,540